Concord Medical Services Holdings Limited
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.9M | $52.6M | $75.7M | $68.4M | $76.2M | $34.2M | $28.5M | $27.8M |
| Cost of Revenue | $62.2M | $63.4M | $86.5M | $90.5M | $85.1M | $32.2M | $30.8M | $24.9M |
| Gross Profit | $3.7M | $-10.8M | $-10.8M | $-22.1M | $-8.9M | $2.0M | $-2.3M | $2.9M |
| Gross Margin | 5.6% | -20.6% | -14.3% | -32.3% | -11.7% | 5.9% | -8.0% | 10.4% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $30.5M | $55.4M | $46.5M | $45.1M | $54.6M | $45.2M | $45.3M | $42.4M |
| Operating Income | $-37.4M | $-72.9M | $-65.2M | $-76.1M | $-71.9M | $-48.4M | $-62.8M | $-43.5M |
| Operating Margin | -56.8% | -138.6% | -86.2% | -111.2% | -94.4% | -141.7% | -220.5% | -156.8% |
| Interest Expense | $21.8M | $26.5M | $23.3M | $17.5M | $11.6M | $12.5M | $4.1M | $6.7M |
| Pretax Income | $-53.4M | $-91.7M | $78.3M | $121.8M | $83.1M | $67.7M | $56.2M | $32.8M |
| Income Tax Expense | $867.0K | $-2.4M | $-3.5M | $-10.3M | $-1.0M | $-5.8M | $-5.6M | $5.0M |
| Net Income | $-13.3M | $-42.2M | $-41.9M | $-71.0M | $-42.6M | $-47.5M | $-44.1M | $-34.2M |
| Net Margin | -20.2% | -80.3% | -55.4% | -103.7% | -55.9% | -139.0% | -154.8% | -123.0% |
| EPS (Basic) | $-0.10 | $-0.32 | $-0.32 | $-0.54 | $-0.98 | $-0.78 | $-0.61 | $-0.40 |
| EPS (Diluted) | $-0.10 | $-0.32 | $-0.32 | $-0.54 | $-0.98 | $-0.78 | $-0.61 | $-0.40 |
| Shares Outstanding (Basic) | 131.1M | 131.1M | 131.1M | 131.1M | 131.1M | 131.1M | 130.2M | 130.2M |
| Shares Outstanding (Diluted) | 131.1M | 131.1M | 131.1M | 131.1M | 131.1M | 131.1M | 130.2M | 130.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |